Cargando…

Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi

BACKGROUND: Early diagnosis has been a bottleneck in the care of chronic liver disease patients and can be addressed by Community-based screening for liver fibrosis using non-invasive diagnostic techniques. OBJECTIVES: The study aimed to determine the prevalence of liver fibrosis and the number need...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagappa, Bharathnag, Ramalingam, Archana, Rastogi, Aayushi, Dubey, Shantanu, Thomas, Sherin Sarah, Gupta, Ekta, Sarin, Shiv Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140251/
https://www.ncbi.nlm.nih.gov/pubmed/34041187
http://dx.doi.org/10.4103/jfmpc.jfmpc_1441_20
_version_ 1783696154398031872
author Nagappa, Bharathnag
Ramalingam, Archana
Rastogi, Aayushi
Dubey, Shantanu
Thomas, Sherin Sarah
Gupta, Ekta
Sarin, Shiv Kumar
author_facet Nagappa, Bharathnag
Ramalingam, Archana
Rastogi, Aayushi
Dubey, Shantanu
Thomas, Sherin Sarah
Gupta, Ekta
Sarin, Shiv Kumar
author_sort Nagappa, Bharathnag
collection PubMed
description BACKGROUND: Early diagnosis has been a bottleneck in the care of chronic liver disease patients and can be addressed by Community-based screening for liver fibrosis using non-invasive diagnostic techniques. OBJECTIVES: The study aimed to determine the prevalence of liver fibrosis and the number needed to screen (NNS) to prevent the progression of fibrosis, among adults visiting urban Primary Health Centres (PHC). METHODS: A facility-based cross-sectional study was conducted from May 2018 to April 2019 in 72 randomly chosen PHCs using a mobile screening van. A pre-tested questionnaire was used to collect relevant history from adult patients and patient attenders. A venous blood sample was collected for biochemical markers and Transient Elastography was also done to measure Liver stiffness (LSM). LSM ≥6.0 kPa was taken as the cut-off for detecting liver fibrosis. Lifestyle modifications and alcohol cessations were considered as interventions for non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) respectively, to calculate NNS. RESULTS: 7624 participants were recruited in the study with a mean age of 46 ± 12 years. Around 35.5% of participants had liver fibrosis and 3% had cirrhosis. Nearly 4% had ALD and 30% had NAFLD. NNS for preventing progression of fibrosis for ALD and NAFLD was 12 and 29 respectively. NNS was least among obese, diabetes and hypertensive participants. CONCLUSION: One-third of adults visiting urban PHCs had significant liver fibrosis. Low NNS to prevent the progression of fibrosis to cirrhosis among alcohol users and other high-risk groups, substantiates the need for screening among these groups.
format Online
Article
Text
id pubmed-8140251
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-81402512021-05-25 Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi Nagappa, Bharathnag Ramalingam, Archana Rastogi, Aayushi Dubey, Shantanu Thomas, Sherin Sarah Gupta, Ekta Sarin, Shiv Kumar J Family Med Prim Care Original Article BACKGROUND: Early diagnosis has been a bottleneck in the care of chronic liver disease patients and can be addressed by Community-based screening for liver fibrosis using non-invasive diagnostic techniques. OBJECTIVES: The study aimed to determine the prevalence of liver fibrosis and the number needed to screen (NNS) to prevent the progression of fibrosis, among adults visiting urban Primary Health Centres (PHC). METHODS: A facility-based cross-sectional study was conducted from May 2018 to April 2019 in 72 randomly chosen PHCs using a mobile screening van. A pre-tested questionnaire was used to collect relevant history from adult patients and patient attenders. A venous blood sample was collected for biochemical markers and Transient Elastography was also done to measure Liver stiffness (LSM). LSM ≥6.0 kPa was taken as the cut-off for detecting liver fibrosis. Lifestyle modifications and alcohol cessations were considered as interventions for non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) respectively, to calculate NNS. RESULTS: 7624 participants were recruited in the study with a mean age of 46 ± 12 years. Around 35.5% of participants had liver fibrosis and 3% had cirrhosis. Nearly 4% had ALD and 30% had NAFLD. NNS for preventing progression of fibrosis for ALD and NAFLD was 12 and 29 respectively. NNS was least among obese, diabetes and hypertensive participants. CONCLUSION: One-third of adults visiting urban PHCs had significant liver fibrosis. Low NNS to prevent the progression of fibrosis to cirrhosis among alcohol users and other high-risk groups, substantiates the need for screening among these groups. Wolters Kluwer - Medknow 2021-03 2021-04-08 /pmc/articles/PMC8140251/ /pubmed/34041187 http://dx.doi.org/10.4103/jfmpc.jfmpc_1441_20 Text en Copyright: © 2021 Journal of Family Medicine and Primary Care https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Nagappa, Bharathnag
Ramalingam, Archana
Rastogi, Aayushi
Dubey, Shantanu
Thomas, Sherin Sarah
Gupta, Ekta
Sarin, Shiv Kumar
Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi
title Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi
title_full Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi
title_fullStr Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi
title_full_unstemmed Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi
title_short Number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: An experience from Delhi
title_sort number needed to screen to prevent progression of liver fibrosis to cirrhosis at primary health centers: an experience from delhi
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140251/
https://www.ncbi.nlm.nih.gov/pubmed/34041187
http://dx.doi.org/10.4103/jfmpc.jfmpc_1441_20
work_keys_str_mv AT nagappabharathnag numberneededtoscreentopreventprogressionofliverfibrosistocirrhosisatprimaryhealthcentersanexperiencefromdelhi
AT ramalingamarchana numberneededtoscreentopreventprogressionofliverfibrosistocirrhosisatprimaryhealthcentersanexperiencefromdelhi
AT rastogiaayushi numberneededtoscreentopreventprogressionofliverfibrosistocirrhosisatprimaryhealthcentersanexperiencefromdelhi
AT dubeyshantanu numberneededtoscreentopreventprogressionofliverfibrosistocirrhosisatprimaryhealthcentersanexperiencefromdelhi
AT thomassherinsarah numberneededtoscreentopreventprogressionofliverfibrosistocirrhosisatprimaryhealthcentersanexperiencefromdelhi
AT guptaekta numberneededtoscreentopreventprogressionofliverfibrosistocirrhosisatprimaryhealthcentersanexperiencefromdelhi
AT sarinshivkumar numberneededtoscreentopreventprogressionofliverfibrosistocirrhosisatprimaryhealthcentersanexperiencefromdelhi